Press Releases

ALACHUA, Fla. and TAMPA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the first surgical implantations of its newest product, Avive+ Soft Tissue Matrix™.

“We are excited to expand our offering in nerve protection with the introduction of this resorbable barrier to support the critical phases of healing for nerve injuries,”... (continue reading...)

WASHINGTON, April 29, 2024 /PRNewswire/ --

Statement attributable to:Octavia Peck Palmer, PhDPresident, Association for Diagnostics & Laboratory Medicine (formerly AACC)

"We at the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) strongly disagree with the Food and Drug Administration's (FDA's) decision to issue a final rule... (continue reading...)

Toronto, Ontario--(Newsfile Corp. - April 29, 2024) - West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTC: WIBFF) ("West Island" or the "Company") is pleased to announce the Company has completed a non-brokered private placement financing (the "Financing") of 2,051,282 units (the "Units") at a price of $0.0975 per Unit for gross proceeds of up to $200,000 and confirms issuance of securities.

Each such Unit is composed of one (1) common share ("Common Share") in the... (continue reading...)

•   Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology (ASH) 65th Annual Meeting

•   Execution of strategic collaboration and investment agreements with AstraZeneca

•   Cécile Chartier, Ph.D., appointed as a director of the Cellectis’ Board of Directors

•   Drawdown of the second tranche of €15 million under the credit facility agreement entered into with the... (continue reading...)

Application Pending to Transfer Shares to OTCQX

PLANO, Texas, April 29, 2024 /PRNewswire/ -- Direct Selling Acquisition Corp. (NYSE: DSAQ) (the "Company") today announced that it has received a notice letter (the "Delisting Notice") from the New York Stock Exchange ("NYSE") that the staff of NYSE Regulation has determined to commence proceedings to delist its Class A common stock, par value $0.0001 per share (the "Common Stock") and units, each consisting of one... (continue reading...)